Company / PP&E per Share
Esperion Therapeutics, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2025
5-year range
$0.00 / $0.02
FY2021-FY2025
Trend
+19.8%
vs FY2024
Sector context
#182 of 191
Health Care
What the data says
Among 191 Health Care companies, Esperion Therapeutics, Inc. is in the bottom 5% for pp&e per share. PP&E per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2023 to $0.05 in FY2020.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -48.8%.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -13.0%
- 5-Year CAGR
- -48.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 191This company $0.00 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 19.8% year-over-year.
- Ranks #182 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
- Lowest pp&e per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | +19.8% |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.00 | -89.9% |
| FY2021 | $0.02 | -47.2% |
| FY2020 | $0.05 | +8.7% |
| FY2019 | $0.04 | +119.6% |
| FY2018 | $0.02 | +6.9% |
| FY2017 | $0.02 | -39.2% |
| FY2016 | $0.03 | -18.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026